MAVELERTINIB

UNII:	YXX2180047
Type:	INGREDIENT SUBSTANCE
Formula:	C₁₈H₂₂FN₉O₂
Preferred Substance Name:	MAVELERTINIB
InChIKey:	JYIUNVOCEFIUIU-GHMZBOCLSA-N
GSRS Full Record:	YXX2180047 i

1776112-90-3
2-PROPENAMIDE, N-((3R,4R)-4-FLUORO-1-(6-((3-METHOXY-1-METHYL-1H-PYRAZOL-4-YL)AMINO)-9-METHYL-9H-PURIN-2-YL)-3-PYRROLIDINYL)-
EGFR T790M INHIBITOR PF-06747775
MAVELERTINIB [USAN]
Mavelertinib [WHO-DD]
N-((3R,4R)-4-FLUORO-1-(6-((3-METHOXY-1-METHYL-PYRAZOL-4-YL)AMINO)-9-METHYL-PURIN-2-YL)PYRROLIDIN-3-YL)PROP-2-ENAMIDE
N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methylpyrazol-4-yl)amino]-9-methylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide
PF-06747775
mavelertinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MAVELERTINIB

Synonyms and Mappings

Resources